Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Gewählte Publikation:

Liutkevych, K.
Dupilumab (Dupixent®): Efficacy and treatment satisfaction in patients with atopic dermatitis
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2024. pp.

 

Autor*innen der Med Uni Graz:

Betreuer*innen:

Legat Franz

Repelnig Maria-Lisa

Altmetrics:

Abstract:

Atopic dermatitis (AD) is the most common chronic inflammatory skin condition worldwide. In 2017, dupilumab was approved in the EU for use in moderate to severe forms of AD, providing a reliable long-term therapy and relief of disease symptoms. Alongside the reduction of the symptoms, it offered a long-lasting improvement in quality of life, reducing itch and sleep disturbances. As of 2020, there was no data from Austria regarding the long-term use of dupilumab for this indication.

© Med Uni Graz • Impressum